About GROW
GROW is a company based in London (United Kingdom) founded in 2017 by Ian Atkinson and Ben Langley. It operates as a Direct-to-Consumer (D2C) and B2B2C. GROW has raised $12.62 million across 2 funding rounds. The company has 13 employees as of December 31, 2020. GROW has completed 1 acquisition, including Sanoid. GROW offers products and services including Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils. GROW operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter London, United Kingdom
- Employees 13 as on 31 Dec, 2020
- Founders Ian Atkinson, Ben Langley
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Grow Group Ltd
-
Annual Revenue
$7.07 M (USD)469as on Dec 31, 2021
-
Net Profit
-$1.99 M (USD)32as on Dec 31, 2021
-
EBITDA
-$2.1 M (USD)31as on Dec 31, 2021
-
Total Equity Funding
$12.62 M (USD)
in 2 rounds
-
Latest Funding Round
$4.68 M (USD), Series C
Aug 31, 2021
-
Investors
Not available
-
Employee Count
13
as on Dec 31, 2020
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GROW
GROW offers a comprehensive portfolio of products and services, including Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils.
Medicinal cannabis products are provided for various conditions.
Herbal cannabis flowers are offered for vaporization use.
Cannabis oils are supplied for sublingual administration.
People of GROW
Unlock access to complete
Software Development Team
2 people
Leadership Team
2 people
Finance and Accounting
1 people
CSO Team
1 people
Unlock access to complete
Funding Insights of GROW
GROW has successfully raised a total of $12.62M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $4.68 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by GROW
GROW has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sanoid.
Investment portfolio details for GROW
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabinoid cosmetics, nutraceuticals, and pharmaceuticals are cultivated and manufactured.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for GROW
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - GROW
Detailed financials for GROW
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Grow Comparisons
Peer comparison for GROW
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GROW
GROW operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Medical cannabis products are provided based on GMP processes.
|
|
| Locked | Locked | Locked |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| Locked | Locked | Locked |
Manufacturer of medicinal cannabis for therapeutic use
|
|
| Locked | Locked | Locked |
Developer of medical cannabis products
|
Detailed competitors of GROW
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Grow
Complete news archive for GROW
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GROW
GROW was founded in 2017 and raised its 1st funding round 3 years after it was founded.
GROW is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Ben Langley is the current CEO of GROW. They have also founded this company.
GROW is a funded company, having raised a total of $12.62M across 2 funding rounds to date.
As of Dec 31, 2020, the latest employee count at GROW is 13.
Annual revenue of GROW is $7.07M as on Dec 31, 2021.
GROW Group LTD is a biopharmaceutical entity established in 2017, dedicated to the development and supply of cannabis-based medicinal products. Operations are conducted through a vertically integrated model and partnerships to ensure a broad supply of differentiated medicines. The company targets various medical conditions such as epilepsy, cancer, and chronic pain across multiple regions including the UK, Germany, and Iberia. Solutions are provided to improve patient outcomes through innovative approaches and consistent supply chains.
GROW's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
GROW offers Cannabis-Based Medicinal Products, Medical Cannabis Flowers, and Medical Cannabis Oils.
GROW has made 1 acquisition, including Sanoid.